Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: tipiracil

SUNLIGHT trial meets primary endpoint in refractory metastatic CRC

Presented By
Prof. Josep Tabernero, Val d’Hebron University Hospital and Institute of Oncology, Spain
Trial
Phase 3, SUNLIGHT
Conference
ASCO GI 2023

17 March, 2023 08:45

OS benefit for trifluridine/tipiracil in advanced gastric cancer from third-line onward

Presented By
Prof. Josep Tabernero, Vall d'Hebron Institute of Oncology, Spain
Trial
TAGS
Conference
ASCO GI 2021

12 March, 2021 11:44

Final OS analyses comparing trifluridine/tipiracil + bevacizumab versus capecitabine + bevacizumab in first-line unresectable mCRC patients noneligible for intensive therapy

Presented By
Prof. Eric Van Cutsem, KU Leuven, Belgium
Trial
Phase 2, TASCO1
Conference
ASCO GI 2021

12 March, 2021 11:35
site created by:   

© 2021 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy